Drawing for XEMPLAR

USPTO serial 87898615

XEMPLAR

Reviewed by CopyMark Law Group

Reg. 5801704Status 710
Filing date
Status date
Registration date
Jul 9, 2019
Examiner
MARTIN, CHRISTINE C
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with XEMPLAR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jenny Lee

JENNY LEE THE DOBRUSIN LAW FIRM, P.C.29 W. LAWRENCE ST., SUITE 210PONTIAC, MI 48342UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biochemical, and biological preparations, namely, antibodies and fragments of antibodies for use in the development of reagents for industrial and scientific use; biochemical and biological preparations, namely, antibodies and fragments of antibodies for scientific or research useSECTION 8 - CANCELLEDDec 9, 2018
005Pharmaceutical preparations and substances for the treatment of cancer, inflammatory diseases, and other conditions which can be treated or ameliorated by antibodies binding to, or activation or blocking of, a target antigen; antibodies and fragments of antibodies for use in pharmaceutical preparationsSECTION 8 - CANCELLEDDec 9, 2018
042Scientific, biological, and medical research; consulting services in the fields of biotechnology, pharmaceutical research and development, and design and development of proteins, enzymes, biologics, and drug formulations; scientific and technological services, namely, research in the fields of chemistry and molecular biology, namely, protein and biologics detection, characterization, analysis and testing; research and development services in connection with the design, synthesis and assembly of nucleic acids, peptides, proteins, cells, nucleic acid arrays, peptide arrays, and protein arraysSECTION 8 - CANCELLEDApr 5, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 23, 2026C8..CANCELLED SEC. 8 (6-YR)—
Jul 9, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 9, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 7, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jun 6, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 17, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 17, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 16, 2019ALIEASSIGNED TO LIE—
May 9, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 20, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 20, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 20, 2019CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 7, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 7, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 11, 2019IUAFUSE AMENDMENT FILED—
Jan 11, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Nov 27, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 2, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 2, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 12, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 27, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 20, 2018DOCKASSIGNED TO EXAMINER—
May 8, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 2, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance